Physician profile
Cara E Holohan
NPI 1114949138
$851.76
in general payments reported to CMS, 2019-2025
21 companies · $210 in 2025
The $210 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $162 · 2022: $377 · 2023: $15.33 · 2024: $87.84 · 2025: $210.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $313.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $313.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $166.91 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $106.92 | 2021-2022 | |
| Biogen, INC. | $81.22 | 2025 | Zurzuvae |
| Genzyme Corporation | $75.61 | 2025 | |
| Pfizer INC. | $51.10 | 2022-2024 | |
| Takeda Pharmaceuticals U.S.A., INC. | $47.72 | 2021-2022 | |
| Amgen INC. | $40.38 | 2021-2022 | |
| Novo Nordisk INC | $34.48 | 2021-2022 | |
| Astellas Pharma US INC | $28.66 | 2025 | Veozah |
| Glaxosmithkline, LLC. | $26.10 | 2021 | |
| Boston Scientific Corporation | $24.58 | 2025 | Watchman |
| Abbott Laboratories | $23.67 | 2022 | |
| Lilly USA, LLC | $18.23 | 2022 | |
| Millicent US INC | $17.71 | 2024 | Intrarosa, Femring |
| Arbor Pharmaceuticals, INC. | $17.59 | 2021 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $17.56 | 2024 | Myfembree |
| Seqirus USA INC | $16.38 | 2024 | Fluad, Flucelvax |
| Astrazeneca Pharmaceuticals LP | $15.33 | 2023 | Farxiga |
| Amarin Pharma, INC. | $14.18 | 2021 | |
| Agile Therapeutics, INC. | $14.12 | 2024 | Twirla |
| Biotronik INC. | $13.31 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cara Holohan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.